India to be among top 10 pharma markets globally by 2020India's pharmaceutical industry is on good growth trajectory and is likely to be among the top 10 global markets in value terms by 2020, ac...
- AstraZeneca launches heart drug 'Brilinta' in India
AstraZeneca Pharma India today launched its patented antiplatelet drug Brilinta, used to prevent heart attack, after receiving approval fro...
- Hit by red tape, clinical trial companies eye South-East Asia for expansion
Clinical trial companies are looking at South East Asian countries to expand their business and escape the red tape of Indian authorities.
- Drug approvals fall on account of tardy & tedious process by NDAC
Cos allege NDAC has not been sticking to its deadline of giving decision within six weeks & when the committees meet, the approval is outri...
- Drug Regulator office has gone defunct as a quasi regulatory body takes charge of crucial approvals
Drug companies say that due to this committee, the DCGI has become non accountable to issues of drug approvals.